Related Experiment Videos
HelloType1 Digital Education Platform for Individuals With Type 1 Diabetes in Southeast Asia: Data Analytics Study
Sze May Ng1,2, Soe Nyi Nyi1, Muhammad Yazid Jalaludin3
1Faculty of Health, Social Care and Medicine, Edge Hill University, St Helens Rd, Ormskirk, England, L39 4QP, United Kingdom, 44 1695656163.
JMIR Formative Research
|July 17, 2026
Summary
The HelloType1 digital platform significantly expanded its reach in Southeast Asia, showing strong user engagement with practical type 1 diabetes self-management content. This highlights the potential of accessible digital health education models.
Area of Science:
- Digital health interventions
- Diabetes education
- Public health in Southeast Asia
Background:
- Type 1 diabetes presents significant challenges in Southeast Asia due to limited healthcare infrastructure and resources.
- Barriers include delayed diagnosis, poor self-management, and health inequities.
- The COVID-19 pandemic highlighted the need for accessible diabetes information.
Purpose of the Study:
- To evaluate the reach, usage, and engagement of the HelloType1 digital educational platform in Southeast Asia from 2021 to 2024.
- Assess the platform's effectiveness in providing type 1 diabetes information across the region.
- Examine user engagement patterns and content relevance.
Main Methods:
- Descriptive analysis of website analytics (Google Analytics 4) and social media metrics (Meta Business Suite).
- Comparison of metrics over time and by country to understand platform adoption.
- Analysis of user demographics and content engagement patterns.
Main Results:
- Significant growth observed: unique website users increased from 1,178 in 2021 to 40,361 in 2024.
- Pageviews increased substantially, indicating growing content consumption and engagement.
- Platform use was predominantly mobile-based, with strong engagement among adults aged 25-54. Organic search became the primary traffic source.
- Facebook followers grew, and engagement rates improved, with notable country-specific interaction patterns.
- Content on practical self-management topics like blood glucose monitoring and insulin treatment showed high reach and interaction.
Conclusions:
- The HelloType1 platform demonstrates robust growth, mobile-first utilization, and search-driven visibility.
- Engagement is high for practical self-management content, validating the model's utility.
- Findings support the feasibility of low-cost, multilingual digital education for type 1 diabetes.
- Future research should assess the impact on knowledge, behavior, and clinical outcomes.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...